Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

189.32
Delayed Data
As of 4:00pm ET
 -1.88 / -0.98%
Today’s Change
119.37
Today|||52-Week Range
199.95
+47.86%
Year-to-Date
4 Hot ETF Charts of Q2 Earnings Season
Aug 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close191.20
Today’s open190.74
Day’s range189.15 - 192.46
Volume882,072
Average volume (3 months)1,027,318
Market cap$28.0B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-0.97%
Earnings growth (this year)+9.61%
Earnings growth (next 5 years)+14.43%
Revenue growth (last year)+8.05%
P/E ratio37.9
Price/Sales7.90
Price/Book12.72

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+4.15+3.29%
BIVVBioverativ Inc+0.04+0.07%
NBIXNeurocrine Bioscienc...-0.97-1.83%
EXASExact Sciences Corp+0.41+1.09%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$1.00
Annual revenue (last year)$2.4B
Annual profit (last year)$454.1M
Net profit margin18.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Executive VP-Operations, Products &
Strategy
Ostadan Omead
Corporate headquarters
San Diego, California

Forecasts